MedPath

Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

Phase 3
Completed
Conditions
Psoriasis
Interventions
Drug: Vehicle
Registration Number
NCT01878461
Lead Sponsor
Maruho North America Inc.
Brief Summary

This study is to evaluate the efficacy and safety of M518101 in subjects with plaque psoriasis

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
542
Inclusion Criteria
  • Who are able and willing to give signed informed consent
  • Who are male or females aged 18 years or older with plaque psoriasis confirmed by the Investigator.
  • Who have up to 20% of body surface area (BSA) afflicted with plaques
  • Who are neither pregnant nor breast-feeding, nor plan to become pregnant during the study.
Exclusion Criteria
  • Who have a history of allergy to vitamin D3 derivative preparations or a history of relevant drug hypersensitivity.
  • Who are pregnant or lactating.
  • Who have any renal or hepatic insufficiency, or clinically significant cardiac, renal or hepatic disease.
  • Who are not deemed eligible as determined by medical history, physical examination or clinical laboratory safety tests.
  • Who have clinically relevant history or presence of any disease or surgical history other than psoriasis which is likely to affect the conduct of the study
  • Whose serum calcium levels exceed the upper limit of reference range
  • Who have used any investigational medicinal product and/or participated in any clinical study within 60 days of randomization.
  • Who have been treated with systemic therapy within 30days of randomization.
  • Who have treated with biologics within 5 half-lives of the biologics before the day of randomization
  • Who have been treated with topical therapy within 14days before the day of randomization.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
M518101M518101Proper quantity twice a day
VehicleVehicleProper quantity twice a day
Primary Outcome Measures
NameTimeMethod
Investigator Global Assessment8 weeks after dosing
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (33)

T Joseph Raoof

🇺🇸

Encino, California, United States

Agave Clinical Research

🇺🇸

Mesa, Arizona, United States

Grekin Skin Institute

🇺🇸

Warren, Michigan, United States

Washington University Dermatology

🇺🇸

St. Louis, Missouri, United States

Clinical Science Institute

🇺🇸

Santa Monica, California, United States

Dermatology Specialists Research

🇺🇸

Lousville, Kentucky, United States

Center of Central New Jersey

🇺🇸

East Windsor, New Jersey, United States

Skin Search of Rochester

🇺🇸

Rochester, New York, United States

The Center for Clinical and Cosmetic Research

🇺🇸

Aventura, Florida, United States

Northshore University Health System

🇺🇸

Skokie, Illinois, United States

Menter Dermatology Research Institute

🇺🇸

Dallas, Texas, United States

Palmetto Clinical Trial Servises

🇺🇸

Fountain Inn, South Carolina, United States

Karl G Heine Dermatology

🇺🇸

Henderson, Nevada, United States

Jacksonville Center for Clinical Research

🇺🇸

Jacksonville, Florida, United States

Derm Research Center of New York

🇺🇸

Stony Brook, New York, United States

Derm Research

🇺🇸

Louiville, Kentucky, United States

Medical Development Center

🇺🇸

Wilmington, North Carolina, United States

Therapeutics Clinical Research

🇺🇸

San Diego, California, United States

Las Vegas Skin and Cancer Center

🇺🇸

Las Vegas, Nevada, United States

Clinical Trials of Texas

🇺🇸

San Antonio, Texas, United States

Kansas City Dermatology

🇺🇸

Overland Park, Kansas, United States

Medical Center for Clinical Research

🇺🇸

San Diego, California, United States

South Bend Clinic

🇺🇸

South Bend, Indiana, United States

Coastal Clinical Research Center

🇺🇸

Mt Pleasant, South Carolina, United States

Dermatology Consulting Services

🇺🇸

High Point, North Carolina, United States

Central Sooner Research

🇺🇸

Norman, Oklahoma, United States

PMG Research of Charlotte

🇺🇸

Charlotte, North Carolina, United States

Horizons Clinical Research Center

🇺🇸

Denver, Colorado, United States

Tennessee Clinical Research Center

🇺🇸

Nashville, Tennessee, United States

Austin Dermatology Associates

🇺🇸

Austin, Texas, United States

DermResearch

🇺🇸

Austin, Texas, United States

Dermatology Research Center

🇺🇸

Salt Lake City, Utah, United States

Radiant Research

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath